Ajanta Pharma Announces the Launch of Levetiracetam Tablets Print E-mail
By PR Newswire: Biotechnology   
Thursday, 24 March 2016 07:04

Ajanta Pharma's launch of Levetiracetam Tablets is part of an ever-growing portfolio of products that Ajanta has developed for the U.S. market.  To date, the United States Food & Drug Administration (FDA) has granted Ajanta Pharma eight ANDA final approvals and two tentative approvals. An additional 16 ANDAs are pending approval from the FDA.

About Ajanta Pharma

Ajanta Pharma Limited is a fully-integrated pharmaceutical company with global headquarters in Mumbai, India.  Over 6,000 employees are engaged in developing, manufacturing and marketing quality, pharmaceuticals across 35 countries.  Its mission is to serve global healthcare needs through empathy, innovation and technology. 

For more details about Ajanta Pharma USA Inc., please visit us at www.ajantapharmausa.com.

[1] Keppra is a registered trademark of UCB Pharma

Photo - http://photos.prnewswire.com/prnh/20160324/347728

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ajanta-pharma-announces-the-launch-of-levetiracetam-tablets-300241012.html

SOURCE Ajanta Pharma USA Inc.

Related Links

http://www.ajantapharmausa.com

Read more http://www.prnewswire.com/news-releases/ajanta-pharma-announces-the-launch-of-levetiracetam-tablets-300241012.html




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter